Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors

K. P. Papadopoulos; M. Gutierrez; L. R. Duska; L. Gandhi; A. Bommi-Reddy; E. Adams; J. Jauch-Lembach; D. W. Rasco

doi:10.1016/S0959-8049(22)00981-9

Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors

K. P. Papadopoulos
, M. Gutierrez
, L. R. Duska
, L. Gandhi
, A. Bommi-Reddy
, E. Adams
, J. Jauch-Lembach
, D. W. Rasco

School of Medicine

START – San Antonio
University of Virginia
Dana-Farber Cancer Institute
Constellation Pharmaceuticals, Inc.
MorphoSys AG

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Original language	English
Pages (from-to)	S67
Journal	European Journal of Cancer
Volume	174
DOIs	https://doi.org/10.1016/S0959-8049(22)00981-9
State	Published - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1016/S0959-8049(22)00981-9

Cite this

Papadopoulos, K. P., Gutierrez, M., Duska, L. R., Gandhi, L., Bommi-Reddy, A., Adams, E., Jauch-Lembach, J., & Rasco, D. W. (2022). Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors. European Journal of Cancer, 174, S67. https://doi.org/10.1016/S0959-8049(22)00981-9

@article{b116bc0659ca465bb3f9275ed93466f3,

title = "Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors",

author = "Papadopoulos, \{K. P.\} and M. Gutierrez and Duska, \{L. R.\} and L. Gandhi and A. Bommi-Reddy and E. Adams and J. Jauch-Lembach and Rasco, \{D. W.\}",

year = "2022",

month = oct,

doi = "10.1016/S0959-8049(22)00981-9",

language = "English",

volume = "174",

pages = "S67",

journal = "European Journal of Cancer",

issn = "0959-8049",

publisher = "Elsevier Ltd",

}

Papadopoulos, KP, Gutierrez, M, Duska, LR, Gandhi, L, Bommi-Reddy, A, Adams, E, Jauch-Lembach, J & Rasco, DW 2022, 'Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors', European Journal of Cancer, vol. 174, pp. S67. https://doi.org/10.1016/S0959-8049(22)00981-9

TY - JOUR

T1 - Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors

AU - Papadopoulos, K. P.

AU - Gutierrez, M.

AU - Duska, L. R.

AU - Gandhi, L.

AU - Bommi-Reddy, A.

AU - Adams, E.

AU - Jauch-Lembach, J.

AU - Rasco, D. W.

PY - 2022/10

Y1 - 2022/10

UR - https://www.scopus.com/pages/publications/85140436094

U2 - 10.1016/S0959-8049(22)00981-9

DO - 10.1016/S0959-8049(22)00981-9

M3 - Article

AN - SCOPUS:85140436094

SN - 0959-8049

VL - 174

SP - S67

JO - European Journal of Cancer

JF - European Journal of Cancer

ER -

Updated Findings and Biomarker Analysis From the Ongoing Phase 1 Study of Enhancer of Zeste Homolog 2 (EZH2) Inhibitor CPI-0209 in Patients With Advanced Solid Tumors

UN SDGs

Access to Document

Other files and links

Cite this